Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate

Multiple Sclerosis

Volumn 11, Issue 2, 2005, Pages 245-248

  Nolden, Silke ^a   Casper, C ^b   Kuhn, A ^b   Petereit, H F ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Dermatohistol Gemeinschaftsabor   (Germany)

Author keywords

Glatiramer acetate; Infiltration; Jessner Kanof; Lymphocytic infiltration; Multiple sclerosis; Pseudolymphoma; Side effect

Indexed keywords

GLATIRAMER;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG SAFETY; DRUG SELF ADMINISTRATION; HEMATOMA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; INJECTION SITE REACTION; JESSNER KANOF LYMPHOCYTIC INFILTRATION; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE SCLEROSIS; PSEUDOLYMPHOMA; RECURRENT DISEASE; SKIN BIOPSY; SKIN BURNING SENSATION; SKIN INDURATION; T LYMPHOCYTE;

ADULT; HUMANS; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; PSEUDOLYMPHOMA; SKIN DISEASES;

EID: 15544391148     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1130cr     Document Type: Article

References (16)

1. Cerio R, Oliver GF, Jones EW, Winkelmann RK. The heterogeneity of Jessner's lymphocytic infiltration of the skin. Immunohistochemical studies suggesting one form of perivascular lymphocytoma. J Am Acad Dermatol 1990; 23: 63-67.
2. Toonstra J, Wildschut A, Boer J, Smeenk G, Willemze R, van der Putte SC et al. Jessner's lymphocytic infiltration of the skin. A clinical study of 100 patients. Arch Dermatol 1989; 125: 1525-30.
3. Braun-Falco O, Plewig G, Wolff HH. Dermatologie und Venerologie, fourth edition. Heidelberg: Springer Verlag, 1996: 1392-93.
4. Jessner M, Kanof B. Lymphocytic infiltration of the skin. Arch Dermatol Syphiol 1953; 68: 447-49.
5. Liu V, McKee PH. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues. Adv Anat Pathol 2002; 9: 79-100.
6. Kalimo K, Rasanen L, Aho H, Maki J, Mustikkamki UP, Rantala I. Persistent cutaneous pseudolymphoma after intradermal gold injection. J Cutan Pathol 1996; 23: 328-34.
7. Rijlaarsdam U, Scheffer E, Meijer CJ, Kruyswijk MR, Willemze R. Mycosis fungoides-like lesions associated with phenytoine and carbamazepine therapy. J Am Acad Dermatol 1991; 24: 216-20.
8. Stavrianeas NG, Katoulis AC, Kanelleas A, Hatziolou E, Georgala S. Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination. Dermatology 2002; 205: 166-68.
9. Fridkis-Hareli M et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen presenting cells: specificity and promiscuity. Proc Natl Acad Sci 1994; 91: 4872-76.
10. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone) induces degenerate th2 polarized immune responses in patients with multiple sclerosis. J Glin Invest 2000; 105: 967-76.
11. Aharoni R, Teitelbaum D, Sela M, Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T-cell lines and clones of the Th2 type induced by copolymer 1. J Neuroimmunol 1998; 91: 135-46.
12. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al. and the Copolymer 1 Multiple sclerosis Study Group. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995; 45: 1268-76.
13. Schiller PI, Flaig MJ, Puchta U, Kind P, Sander CA. Detection of clonal T-cells in lichen planus. Arch Dermatol Res 2000; 292 568-69.
14. Gaudez C, Regnier S, Aractingi S, Heinzlef O. Livedo-like dermatitis (Nicolau's syndrome) after injection of copolymer-1 (glatiramer acetate). Rev Neurol 2003; 159: 571-73.
15. Hofstadt U, Leclaire J, Raguz JM, Hilker O, Haneke E, Jörg J. Delayed-type hypersensitivity to glatiramer acetate (Copaxone): report of three cases. J Neurol 1999; 245: 418.
16. Windhagen A, Maniak S, Marckmann S, Lindert RB, Heidenreich F, Blasczyk R. Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate. J Neurol Neurosurg Psychiatry 2001; 70: 415-16.